|
Omalizumab - Concentration/Dosage 150 Mg, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Presentation Form Vial-Ampule, Subcutaneous Administration Route, Pancreatin - Concentration/Dosage 10,000 Iu, Pharmaceutical Form Capsule, Oral Administration Route, Pancreatin - Concentration/Dosage 25,000 Iu, 01/08/2025, Penicillamine - Concentration/Dosage 250 Mg, Oral Administration Route, Risperidone - Concentration/Dosage 1 Mg, Tablet Pharmaceutical Form, Risperidone - Concentration/Dosage 1 Mg/Ml, Pharmaceutical Form Oral Solution, Form Bottle Presentation, Risperidone - Concentration/Dosage 2 Mg, Risperidone - Concentration/Dosage 3 Mg, Rivastigmine - Concentration/Dosage 2 Mg/Ml, Ferric Hydroxide, Saccharate - Concentration/Dosage 20 Mg/Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form With 5Ml , Via De Administracao Intravenous Or Intravenous, Sacubitril/Valsartan - Sacubitril Valtarsana Sodica Hydrada 50 Mg, In Coated Tablet, Packed In Blister Or Strip As Stated In The Product Description. The Packaging Must Bear External Identification Data, Batch, Manufacturing And Expiration Dates., Sacubitril/Valsartana - Sacubitril Valtarsana Sodica Hidratada 100 Mg, Sacubitril/Valsartan - Sacubitril Valtarsana Sodica Hidratada 200 Mg, Selexipague - In Tablets Coated With 0.2 Mg, Packed In Oustrip Blister, As Appeared In The Product Registration. The Packaging Must Bear External Identification Data, Batch Number, Manufacturing Date And Expiration Date. The Product Must Have A Minimum Validity Of 12 Months From The Delivery Date At The Requesting Unit., 4 Mg, 6 Mg, 8 Mg, Selexipague - In Tablets Coated With 1.0 Mg, Triptorelin - Concentration/Dosage 3.75 Mg, Pharmaceutical Form Lyophilized Microgranules For Injectable Suspension, Presentation Form Ampoule Bottle + Diluent, Intramuscular Or Subcutaneous Administration Route, Triptorelin - Concentration/Dosage 11, 25 Mg, Intramuscular Administration Route
|
